Molecular Diagnostics Europe 2018 | Cell-Based NIPD: Where Are We Now and Where Are We Going? - a podcast by Cambridge Healthtech Podcasts

Patrizia Paterlini-Brechot spoke to CHI to discuss her work in cell-based non-invasive prenatal diagnosis and some of the challenges in commercializing this technique. She also discusses the impact commercialized NIPD tests will have on the field of prenatal diagnosis and some of the new frontiers she expects will be next. Dr. Paterlini-Brechot is speaking at the Advances in prenatal Molecular Diagnostics meeting, part of Molecular Diagnostics Europe, taking place 22-24 May 2018 in Lisbon, Portugal

For more information, please visit http://www.MolecularDXEurope.com/Prenatal-Dx/

Further episodes of CHI Podcasts

Further podcasts by Cambridge Healthtech Podcasts

Website of Cambridge Healthtech Podcasts